To Expand Domestic Vaccine Manufacturing CapacityOTTAWA, Canada--(BUSINESS WIRE)--#AAV--Virica Biotech Inc. (“Virica”), a leading supplier and developer of novel viral enhancers, announced today it is expanding its bioprocessing facilities and increa
SAB Strengthens GL CHEMTEC’s Mission of Being the Trusted North American CDMO for Small Molecule R&D, Scale-Up and Integrated Drug Delivery SolutionsOAKVILLE, Ontario--(BUSINESS WIRE)--#CDMO--GL CHEMTEC (“GLC”), a specialist in advanced chemist
The farming food company uses energy-efficient Sonic Milling™ technology to make food and beverage products with zero wasteBENTONVILLE, Ark.--(BUSINESS WIRE)--Just in time for Earth Month in April, newly expanded regenerative farming food company Pacif
NIAGARA, Ontario--(BUSINESS WIRE)--extractX Ltd. (“extractX” or the “Company”), announced today that George Barkwell will be ending his tenure at extractX as Chief Financial Officer as his time will be limited as he pursues slowing things down and
Funding will accelerate development of additional system applications and expansion into more fruit crops.TORONTO--(BUSINESS WIRE)--Vivid Machines Inc. today announced successful completion of an oversubscribed first close of its seed round funding of
This partnership delivers best-in-class protection products through Assurant’s growing commercial equipment business.ATLANTA--(BUSINESS WIRE)--Assurant, Inc. (NYSE: AIZ), a leading global business services company that supports, protects, and connects
VANCOUVER, British Columbia--(BUSINESS WIRE)--Ondine Biomedical (OBI:LON), a Canadian life sciences company, reported that photodisinfection being developed for food processing demonstrated high efficacy against key food-borne pathogens. Results of the pr
Grant funds Ventus’ development of its highly differentiated brain-penetrant NLRP3 inhibitorsWALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a biopharmaceutical company utilizing structural biology and a proprietary computational chemi
Eight Poster Presentations Include Results from 12-Month Safety Extension Trial of Investigational Treatment NOV03 (Perfluorohexyloctane), as well as Data on XIPERE® (Triamcinolone Acetonide Injectable Suspension) for Suprachoroidal UseVAUGHAN, Ontario-
Proprietary ROVEr™ platform enables design of next-generation radiopharmaceuticals with tunable pharmacokinetic (PK) properties to maximize therapeutic effect and mitigate systemic toxicities Potential for alpha- or beta-emitting radiopharmaceuticals,
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.